Christina Ruhlmann
@RuhlmannC
Followers
78
Following
94
Media
3
Statuses
20
Clinical Oncology, Melanoma, Supportive Care, Immunotherapy, Immunotoxicity, ICiTox Research Centre
Odense, Danmark
Joined February 2012
Abstract submissions for #MASCC24 are now open! We encourage submissions from both new and experienced researchers. Submit your abstract by January 8 (or December 18 if you plan to apply for a Conference Scholarship). https://t.co/TjdIx2CE4F
#SuppOnc @OncoAlert
0
8
23
Excellent presentation by Sofie Detlefsen of the results from the DANGER-emesis study demonstrating favourable safety profile during weekly administration of antiemetic prophylaxis with NEPA+dex during chemo-radiation for cervical cancer @CancerCareMASCC #MASCC24 #antiemetics
0
0
8
Our study groups are the core of MASCC. Thank you to each of our study group chairs and co-chairs for all of your hard work and leadership throughout the year! #MASCC24
0
3
17
#MASCC24 plenary session Christina Ruhlmann presents data on irAEs. Fascinating discussion of chronic irAEs that correlates well with our analysis by @SayaJacob3 @OncoAlert @UCSFCancer unclear impact on outcome and PROs. Multidisciplinary teams key.
0
10
25
Next up #MASCC24: @RuhlmannC discusses #immunotherapy toxicities and highlights the lack of guidance around metastatic #survivorship #survonc
1
4
18
@RuhlmannC reminds us of some 🦓 irAEs but they are l I’ll Elu to become more common as adjuvant treatment adopts moe immunotherapy #MASCC24
0
1
3
So happy to participate in #MASCC24 with my co-chair of the emerging agents toxicity working group @RuhlmannC. Come to Lille for this important and exciting meeting! @maryam_lustberg
Our first plenary session of #MASCC24 will focus on the management of emerging toxicities, chaired by Prof @alexchan928 and Dr Didier Mayeur. Speakers: Dr @hoperugo, Dr @RuhlmannC and Dr @ines_vazluis Register today! https://t.co/FLriwgiXBz
#supponc @OncoAlert
0
5
32
Our first plenary session of #MASCC24 will focus on the management of emerging toxicities, chaired by Prof @alexchan928 and Dr Didier Mayeur. Speakers: Dr @hoperugo, Dr @RuhlmannC and Dr @ines_vazluis Register today! https://t.co/FLriwgiXBz
#supponc @OncoAlert
1
2
10
Recommendations for Global Curriculum in #MedicalOncology: result of great collaboration btw @myesmo & @ASCO and the full support of @JCOGO_ASCO & @ESMO_Open
The 2023 edition of the ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology is out! Read the paper in @ESMO_Open 📌 https://t.co/Jbf01N0MlW
2
13
45
#ESMO23 💡is just around the corner! The #Supportive Care and #Palliative Care track delivers excellent content every day! See you in Madrid! @myESMO @ines_vazluis @bosnjaksupport @DrDavidHui @dorothy_keefe @AnneLetsch @ZimmTeamLab JWood GKreye JHerrstedt ASnegovoy TFusi MSaito
0
5
17
Proud to announce the set to ‘recruiting’ status of our RCT The iCaD Study, aiming to improve ICI induced colitis. Huge efforts, collaboration and funding made it possible for us to get so far - thanks to @Kjaer_Soeren @novonordiskfond @NEYEFonden @onko_ouh @OUHhospital #ICiTox
1
1
9
Så er to super stærke ph.d.-studerende skudt i gang i ICiTox - Immunotoxicity Research Centre Region of Southern Denmark - @TenstadHelene og @Kjaer_Soeren #ICiTox @SUND_SDU @onko_ouh
1
1
9